Endologix acquires Pounce thrombectomy system from Surmodics

Endologix announced it has acquired the Pounce thrombectomy system from Surmodics, expanding the company’s portfolio of vascular intervention technologies.

The transaction closed May 18, according to the company.

The FDA-cleared Pounce thrombectomy system is designed for the non-surgical removal of thrombi and emboli from peripheral arteries. The fully mechanical system uses a dual-basket design and a nitinol collection funnel to remove clots without the use of thrombolytic drugs, aspiration or capital equipment.

The platform includes three commercially available configurations — Pounce LP, Pounce and Pounce XL — intended for use in a range of peripheral arterial vessel sizes, including smaller and more distal vessels. The system will continue to be marketed under its existing FDA clearance during a transition period following the acquisition.

“The Pounce thrombectomy system is a strong strategic and clinical fit for Endologix,” said John Liddicoat, president and CEO of Endologix, in a statement. He said the technology complements the company’s vascular intervention portfolio and supports physicians treating peripheral vascular disease.

Endologix said the acquisition broadens its offerings for vascular specialists already using the company’s DETOUR, ALTO and AFX2 platforms. The company said adding a mechanical thrombectomy option will help it address a broader range of peripheral vascular disease treatments.

A group of Surmodics employees supporting the Pounce platform also will join Endologix as part of the deal.

Venkatesh Ramaiah, chief of vascular and endovascular surgery at Pulse Cardiovascular Institute, said combining the technologies under one company provides physicians with additional treatment flexibility for thrombi and emboli in peripheral arteries.

Endologix, based in California, develops devices for the interventional treatment of vascular disease, including technologies for abdominal aortic aneurysms and peripheral vascular disease. The company is owned by Deerfield Management.